Advertisement

Topics

Embera NeuroTherapeutics, Inc. Company Profile

04:44 EDT 21st September 2017 | BioPortfolio

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions that drive craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder, Dr. Nicholas Goeders. Embera is advancing EMB-001 development programs in smoking cessation and cocaine dependence based on these results.


News Articles [14 Associated News Articles listed on BioPortfolio]

Embera NeuroTherapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and other addictions, today announced that Robert (Bob...

Embera NeuroTherapeutics to Present at the 19th Annual Rodman & Renshaw Global ...

Read more...

Embera NeuroTherapeutics, Inc. Announces Positive Topline Data From Phase Ib Cocaine Interaction Study Of EMB-001

  Life Sciences Jobs   ...

Embera reports positive topline data from Phase Ib cocaine interaction study of EMB-001

US-based clinical-stage pharmaceutical firm Embera NeuroTherapeutics has reported positive topline data from the Phase Ib cocaine interaction study of a patented combination product EMB-001.

Embera NeuroTherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 26042017] Prices from USD $250

SummaryEmbera NeuroTherapeutics Inc Embera is a contract research company that discovers and develops new treatments. The company's product includes EMB001, a drug combination for the stress response ...

Embera NeuroTherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27072017] Prices from USD $250

SummaryEmbera NeuroTherapeutics Inc Embera is a contract research company that discovers and develops new treatments. The company's product includes EMB001, a drug combination for the stress response ...

Embera NeuroTherapeutics Announces Positive Topline Data from Phase 1b Cocaine Interaction Study of EMB-001

-- EMB-001 was well-tolerated and no new safety signals were observed when co-administered with cocaine -- -- Preparations are underway for advancement into Phase 2 studi...

Biscayne Readies Phase 1b Trial for Novel Antiepileptic Agent BIS-001 and Receives FDA Orphan Drug Designation for Dravet Syndrome

MIAMI, May 9, 2017 /PRNewswire/ -- Biscayne Neurotherapeutics, Inc., a clinical-stage company developing novel treatments for neurological disorders, today announced that lead compound BIS-001 has rec...

Drugs and Medications [0 Results]

None

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.

Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.

Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist...

Normobaric hyperoxygenation: a potential neuroprotective therapy for acute ischemic stroke?

Tumor Vaccines for Malignant Gliomas.

Despite continued research efforts, glioblastoma multiforme (GBM) remains the deadliest brain tumor. Immunotherapy offers a novel way to treat this disease, the genetic signature of which is not compl...

Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials.

Radiographic endpoints including response and progression are important for the evaluation of new glioblastoma therapies. The current RANO criteria was developed to overcome many of the challenges ide...

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Embera NeuroTherapeutics Inc.

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range ...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a li...

NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorder...

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzh...

More Information about "Embera NeuroTherapeutics, Inc." on BioPortfolio

We have published hundreds of Embera NeuroTherapeutics, Inc. news stories on BioPortfolio along with dozens of Embera NeuroTherapeutics, Inc. Clinical Trials and PubMed Articles about Embera NeuroTherapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embera NeuroTherapeutics, Inc. Companies in our database. You can also find out about relevant Embera NeuroTherapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record